Log in

Relevant bibliographies by topics / Screening of Breast Cancer / Journal articles

To see the other types of publications on this topic, follow the link: Screening of Breast Cancer.

Journal articles on the topic 'Screening of Breast Cancer'

Author: Grafiati

Published: 6 September 2023

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Screening of Breast Cancer.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Yamauchi, Hideko. "Breast Cancer Screening System in USA." Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening) 21, no. 2 (2012): 115–26. http://dx.doi.org/10.3804/jjabcs.21.115.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Gordon, Paula B. "The Impact of Dense Breasts on the Stage of Breast Cancer at Diagnosis: A Review and Options for Supplemental Screening." Current Oncology 29, no. 5 (2022): 3595–636. http://dx.doi.org/10.3390/curroncol29050291.

Full text

Abstract:

The purpose of breast cancer screening is to find cancers early to reduce mortality and to allow successful treatment with less aggressive therapy. Mammography is the gold standard for breast cancer screening. Its efficacy in reducing mortality from breast cancer was proven in randomized controlled trials (RCTs) conducted from the early 1960s to the mid 1990s. Panels that recommend breast cancer screening guidelines have traditionally relied on the old RCTs, which did not include considerations of breast density, race/ethnicity, current hormone therapy, and other risk factors. Women do not all

APA, Harvard, Vancouver, ISO, and other styles

3

Arima, Yuriko. "Breast Cancer Screening Programme in the UK." Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening) 21, no. 2 (2012): 127–37. http://dx.doi.org/10.3804/jjabcs.21.127.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Chou, Yi-Hong. "Evolution of Breast Cancer Screening in Taiwan." Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening) 21, no. 2 (2012): 138–42. http://dx.doi.org/10.3804/jjabcs.21.138.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Schouten, L. J., J. Th Schlangen, J. M. de Rijke, and A. L. M. Verbeek. "Evaluation of the effect of breast cancer screening by record linkage with the cancer registry, the Netherlands." Journal of Medical Screening 5, no. 1 (1998): 37–41. http://dx.doi.org/10.1136/jms.5.1.37.

Full text

Abstract:

Objective To evaluate the effect of a breast cancer screening programme by record linkage with the cancer registry. Setting Breast cancer screening programme in mid- and southern Limburg, the Netherlands. Method The data files of the breast cancer screening programme and the Maastricht Cancer Registry were linked in order to evaluate the effect of breast cancer screening. Only the first primary breast tumour was included in the evaluation. Results From 1990 until 1995 90 001 women participated in the first round of the breast cancer screening programme and 64 637 in subsequent rounds. After th

APA, Harvard, Vancouver, ISO, and other styles

6

Watkins, Elyse, and Toni Jackson. "Implications of breast density for breast cancer screening." JAAPA 37, no. 10 (2024): 32–35. http://dx.doi.org/10.1097/01.jaa.0000000000000127.

Full text

Abstract:

ABSTRACT Extremely dense breasts can be an independent risk factor for breast cancer. A new FDA rule requires that patients be notified of their breast density and the possible benefits of additional imaging to screen for breast cancer. Clinicians should be cognizant of the data about breast cancer risk, breast density, and recommendations to change screening techniques if patients, particularly premenopausal females, have extremely dense breasts but no other known risk factors.

APA, Harvard, Vancouver, ISO, and other styles

7

Mahmoud, Mattia A., Sarah Ehsan, Oluwadamilola M. Fayanju, et al. "Abstract C118: Racial disparities in insurance coverage for supplemental breast cancer screening." Cancer Epidemiology, Biomarkers & Prevention 32, no. 12_Supplement (2023): C118. http://dx.doi.org/10.1158/1538-7755.disp23-c118.

Full text

Abstract:

Abstract Introduction and Purpose: Women with dense breasts have increased risk both for developing breast cancer and false-negative mammograms. Supplemental screening with breast MRI has been shown to shown to significantly increase cancer detection among women with dense breasts. In May 2023, Pennsylvania (PA) mandated insurance coverage of one supplemental screening study (breast MRI or ultrasound ) annually for women with dense breasts. Prior research suggests that Black women have lower breast density on average than white women based on subjective grading from the American College of Rad

APA, Harvard, Vancouver, ISO, and other styles

8

AIRES LIMA, Cátia Cilene, and Carla Daruich de Souza. "Evaluation of the Possible Benefits of Breast Cancer Screening in Women Aged 40 to 49 Years in the Steel Valley Region, Brazil." Archives of Breast Cancer 11, no. 2 (2024): 172–82. http://dx.doi.org/10.32768/abc.2024112172-182.

Full text

Abstract:

Background: This study investigates the effectiveness of mammographic screening for women aged 40 to 49 in Brazil's Steel Valley Region. Despite a Ministry of Health recommendation to start screenings at 50, 25% of breast cancer cases occur in the 40-49 age group. Methods: The retrospective analysis, spanning 2008-2019 at Marcio Cunha Hospital, compared two groups: cancer diagnosed via screening mammography (277) and diagnostic mammography (229). Results: Results showed delayed diagnoses for non-screened women, with 4.16 times higher mortality rate. Screening facilitated earlier detection of l

APA, Harvard, Vancouver, ISO, and other styles

9

Ding, Rui, Yi Xiao, Miao Mo, Ying Zheng, Yi-Zhou Jiang, and Zhi-Ming Shao. "Breast cancer screening and early diagnosis in Chinese women." Cancer Biology & Medicine 19, no. 4 (2022): 450–67. http://dx.doi.org/10.20892/j.issn.2095-3941.2021.0676.

Full text

Abstract:

Breast cancer is the most common malignant tumor in Chinese women, and its incidence is increasing. Regular screening is an effective method for early tumor detection and improving patient prognosis. In this review, we analyze the epidemiological changes and risk factors associated with breast cancer in China and describe the establishment of a screening strategy suitable for Chinese women. Chinese patients with breast cancer tend to be younger than Western patients and to have denser breasts. Therefore, the age of initial screening in Chinese women should be earlier, and the importance of scr

APA, Harvard, Vancouver, ISO, and other styles

10

Calinescu, Gina, Corina Grigoriu, Athir Eddan, et al. "Breast density and breast cancer." Romanian Journal of Medical Practice 16, S7 (2021): 29–32. http://dx.doi.org/10.37897/rjmp.2021.s7.9.

Full text

Abstract:

Breast density is increasingly recognized as an independent risk factor for the development of breast cancer. It has been shown to be associated with a four-to sixfold increase a woman's risk of malignant breast disease. Increased breast density, as identified on mammography, is known to decrease the diagnostic sensitivity of the examination, which is of great concern to women at increased risk for breast cancer. Dense tissue has generally been associated with younger age and premenopausal status, with the assumption that breast density gradually decreases after menopause. However, the actual

APA, Harvard, Vancouver, ISO, and other styles

11

Reungwetwattana, Thanyanan, Julian R. Molina, and Jeanette Y. Ziegenfuss. "Factors and trends in cancer screening in the United States from 2004 to 2010." Journal of Clinical Oncology 30, no. 15_suppl (2012): 1565. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.1565.

Full text

Abstract:

1565 Background: Understanding the prevalence of cancer screening in the US and the factors associated with its accessibility is important for public health promotion. Methods: The 2004 and 2010 Behavioral Risk Factor Surveillance Systems were used to ascertain cancer screening rates among populations indicated for each test by age, gender, and the American Cancer Society recommendation for cancer screenings [fecal occult blood test (FOBT) or endoscopy for colorectal cancer (CRC) screening, digital rectal examination (DRE) or prostate specific antigen (PSA) for prostate cancer screening, clini

APA, Harvard, Vancouver, ISO, and other styles

12

P., Priyadarshini,, Sarathi, S., and Hemavathy, V. "Breast Cancer Screening." CARDIOMETRY, no. 24 (November 30, 2022): 1000–1005. http://dx.doi.org/10.18137/cardiometry.2022.24.10001005.

Full text

Abstract:

Breast cancer is the most frequent cancer in women, impacting one out of every eight women at some point in their lives. Despite the fact that it is more frequent in older women, breast cancer seldom strikes women under the age of 45. Women under the age of 45 account for around 9% of all new cases of breast cancer in the United States. The most important methods for preventing breast cancer deaths are early detection and cutting-edge cancer treatment. Breast cancer that is detected early, when it is little and hasn’t spread, is easier to treat. The most accurate method for identifying breast

APA, Harvard, Vancouver, ISO, and other styles

13

Zheng, Senshuang, Xiaorui Zhang, Marcel J. W. Greuter, Geertruida H. de Bock, and Wenli Lu. "Determinants of Population-Based Cancer Screening Performance at Primary Healthcare Institutions in China." International Journal of Environmental Research and Public Health 18, no. 6 (2021): 3312. http://dx.doi.org/10.3390/ijerph18063312.

Full text

Abstract:

Background: For a decade, most population-based cancer screenings in China are performed by primary healthcare institutions. To assess the determinants of performance of primary healthcare institutions in population-based breast, cervical, and colorectal cancer screening in China. Methods: A total of 262 primary healthcare institutions in Tianjin participated in a survey on cancer screening. The survey consisted of questions on screening tests, the number of staff members and training, the introduction of the screening programs to residents, the invitation of residents, and the number of perfo

APA, Harvard, Vancouver, ISO, and other styles

14

Lynge, Elsebeth, Ilse Vejborg, Zorana Andersen, My von Euler-Chelpin, and George Napolitano. "Mammographic Density and Screening Sensitivity, Breast Cancer Incidence and Associated Risk Factors in Danish Breast Cancer Screening." Journal of Clinical Medicine 8, no. 11 (2019): 2021. http://dx.doi.org/10.3390/jcm8112021.

Full text

Abstract:

Background: Attention in the 2000s on the importance of mammographic density led us to study screening sensitivity, breast cancer incidence, and associations with risk factors by mammographic density in Danish breast cancer screening programs. Here, we summarise our approaches and findings. Methods: Dichotomized density codes: fatty, equal to BI-RADS density code 1 and part of 2, and other mixed/dense data from the 1990s—were available from two counties, and BI-RADS density codes from one region were available from 2012/13. Density data were linked with data on vital status, incident breast ca

APA, Harvard, Vancouver, ISO, and other styles

15

Nigam, Aruna, and Neeti Singhal. "Breast Cancer Screening: Guidelines and Opportunities for Gynecologists." Journal of Colposcopy and Lower Genital Tract Pathology 2, no. 2 (2024): 45–50. http://dx.doi.org/10.4103/jclgtp.jclgtp_13_24.

Full text

Abstract:

Abstract Breast cancer is the most common cancer worldwide and is the leading cause of deaths from cancer among women. It accounts for 12% of all cancer cases worldwide and 39.4% of the total cancer cases in women in India. The number is expected to rise to more than 2.3 lakh cases by the year 2025. As a general instinct, females usually come to gynecologists with problems related to breasts apart from other gynecological problems. Hence, they play a vital role in early detection by identifying the high-risk patients, screening them and spreading awareness. Risk factors for each age group shou

APA, Harvard, Vancouver, ISO, and other styles

16

Bukhari, Hassan, Asim Shaukat, and Nosheen Ahmad. "BREAST CANCER SCREENING;." Professional Medical Journal 24, no. 01 (2017): 42–46. http://dx.doi.org/10.29309/tpmj/2017.24.01.400.

Full text

Abstract:

Objectives: To compare the efficacy of Magnetic resonance imaging andMammography for Breast-Cancer Screening in high risk Women with a Familial or GeneticPredisposition. Study Design: Cross-sectional study. Setting: Department of Radiology AlliedHospital, Faisalabad. Duration: From January 2012 to December 2014, Sample size: 299.Methods: A total of 299 females at high risk of breast cancer were included in this study andthey underwent screening rounds of Mammogram and contrast enhanced dynamic breastMRI once a year with independent readings. Both the imaging modalities were interpreted byexper

APA, Harvard, Vancouver, ISO, and other styles

17

Leung, Jessica, Olena Weaver, Samir Hanash, and Jennifer Dennison. "Abstract P6-03-01: The MERIT Cohort: An MD Anderson Initiative to Integrate Blood and Imaging Biomarkers to Personalize Breast Cancer Risk." Cancer Research 83, no. 5_Supplement (2023): P6–03–01—P6–03–01. http://dx.doi.org/10.1158/1538-7445.sabcs22-p6-03-01.

Full text

Abstract:

Abstract Background: The MERIT cohort (Mammography, Early Detection, Risk Assessment, and Imaging Technologies, 2017-present) has enrolled women receiving annual screening mammograms (MG) at MD Anderson with a primary goal to integrate clinical data and imaging data with blood biomarker profiles to determine risk of developing breast and other cancers. Here we report interim results for breast cancers among post-menopausal women in the cohort categorized based on breast density and BMI and differences between participants who underwent MRI/MG screening vs standard annual MG screening. Methods:

APA, Harvard, Vancouver, ISO, and other styles

18

Huang, Sida, Sarah J. Westvold, Pamela R. Soulos, et al. "Screening History, Stage at Diagnosis, and Mortality in Screen-Detected Breast Cancer." JAMA Network Open 8, no. 4 (2025): e255322. https://doi.org/10.1001/jamanetworkopen.2025.5322.

Full text

Abstract:

ImportanceScreening mammography promotes early detection of breast cancer and is associated with reduced breast cancer mortality. Screening history prior to diagnosis may impact stage at diagnosis and breast cancer mortality but has not been comprehensively examined within a diverse US cohort.ObjectiveTo determine whether having a prior screening is associated with earlier stage at breast cancer diagnosis and lower breast cancer–specific mortality.Design, Setting, and ParticipantsThis cohort study used linked Surveillance, Epidemiology, and End Results–Medicare data of women aged at least 70 y

APA, Harvard, Vancouver, ISO, and other styles

19

Kuhl, Christiane K., Heribert Bieling, Kevin Strobel, Claudia Leutner, Hans H. Schild, and Simone Schrading. "Breast MRI screening of women at average risk of breast cancer: An observational cohort study." Journal of Clinical Oncology 33, no. 28_suppl (2015): 1. http://dx.doi.org/10.1200/jco.2015.33.28_suppl.1.

Full text

Abstract:

1 Background: Breast-MRI is currently recommended for screening women at high-risk of breast-cancer only. However, despite decades of mammographic-screening, breast-cancer continues to represent a major cause of cancer-death also for women at average-risk – suggesting a need for improved methods for early diagnosis also for these women. Therefore, we investigated the utility of supplemental MRI-screening of women who carry an average-risk of breast-cancer. Methods: Prospective observational cohort-study conducted in two academic breast-centers on asymptomatic women at average-risk in the usual

APA, Harvard, Vancouver, ISO, and other styles

20

Barton, Mary B. "Breast cancer screening." Postgraduate Medicine 118, no. 2 (2005): 27–46. http://dx.doi.org/10.3810/pgm.2005.08.1692.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Zorbas, Helen M. "Breast cancer screening." Medical Journal of Australia 178, no. 12 (2003): 651–52. http://dx.doi.org/10.5694/j.1326-5377.2003.tb05397.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Warner, Elizabeth A. "BREAST CANCER SCREENING." Primary Care: Clinics in Office Practice 19, no. 3 (1992): 575–88. http://dx.doi.org/10.1016/s0095-4543(21)00939-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Cooper, Nora. "Breast cancer screening." Nursing Standard 13, no. 31 (1999): 49–52. http://dx.doi.org/10.7748/ns1999.04.13.31.49.c7471.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Freimanis, Rita I., and Margaret Yacobozzi. "Breast Cancer Screening." North Carolina Medical Journal 75, no. 2 (2014): 117–20. http://dx.doi.org/10.18043/ncm.75.2.117.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Tabár, László, and Peter B. Dean. "Breast cancer screening." Medical Journal of Australia 154, no. 7 (1991): 494. http://dx.doi.org/10.5694/j.1326-5377.1991.tb121204.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Kearsley, John H., and Cherrell Hirst. "Breast cancer screening." Medical Journal of Australia 154, no. 7 (1991): 494. http://dx.doi.org/10.5694/j.1326-5377.1991.tb121205.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Cohen, Jonathan, and Joseph Cohen. "Breast cancer screening." Medical Journal of Australia 154, no. 7 (1991): 494. http://dx.doi.org/10.5694/j.1326-5377.1991.tb121206.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Freilich, Herbert. "Breast cancer screening." Medical Journal of Australia 154, no. 11 (1991): 781–82. http://dx.doi.org/10.5694/j.1326-5377.1991.tb121347.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Tabár, László, and Peter B. Dean. "Breast cancer screening." Medical Journal of Australia 154, no. 12 (1991): 853–54. http://dx.doi.org/10.5694/j.1326-5377.1991.tb121395.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Warner, Ellen. "Breast-Cancer Screening." New England Journal of Medicine 365, no. 11 (2011): 1025–32. http://dx.doi.org/10.1056/nejmcp1101540.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Ellman, Ruth. "Breast Cancer Screening." Journal of the Royal Society of Medicine 80, no. 11 (1987): 665–66. http://dx.doi.org/10.1177/014107688708001101.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Donald Acheson, E. "Breast Cancer Screening." Journal of the Royal Society of Medicine 82, no. 8 (1989): 455–57. http://dx.doi.org/10.1177/014107688908200804.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Owens, R. Glynn, and Jennifer J. Ashcroft. "Breast Cancer Screening." Journal of Psychosocial Oncology 4, no. 4 (1987): 15–26. http://dx.doi.org/10.1300/j077v04n04_02.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

GEMIGNANI, MARY L. "Breast Cancer Screening." Clinical Obstetrics and Gynecology 54, no. 1 (2011): 125–32. http://dx.doi.org/10.1097/grf.0b013e318208020d.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

FELDMAN, ELIZABETH D., BRIDGET A. OPPONG, and SHAWNA C. WILLEY. "Breast Cancer Screening." Clinical Obstetrics and Gynecology 55, no. 3 (2012): 662–70. http://dx.doi.org/10.1097/grf.0b013e31825ca884.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

EDDY, D. M. "Breast Cancer Screening." JNCI Journal of the National Cancer Institute 81, no. 3 (1989): 234–35. http://dx.doi.org/10.1093/jnci/81.3.234.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Palmieri, C., S. Fishpool, and H. O. Dickinson. "Breast cancer screening." BMJ 321, no. 7260 (2000): 567. http://dx.doi.org/10.1136/bmj.321.7260.567/b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Witcombe, J. B. "Breast cancer screening." Clinical Radiology 44, no. 4 (1991): 287. http://dx.doi.org/10.1016/s0009-9260(05)80203-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Kirkpatrick, A. E. "Breast cancer screening." Clinical Radiology 44, no. 4 (1991): 287. http://dx.doi.org/10.1016/s0009-9260(05)80204-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Wilbanks, Sandy. "Breast Cancer Screening." Journal for Nurse Practitioners 13, no. 4 (2017): e217. http://dx.doi.org/10.1016/j.nurpra.2017.03.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Wilbanks, Sandy. "Breast Cancer Screening." Journal for Nurse Practitioners 13, no. 4 (2017): e219. http://dx.doi.org/10.1016/j.nurpra.2017.03.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Jatoi, Ismail. "Breast cancer screening." American Journal of Surgery 177, no. 6 (1999): 518–24. http://dx.doi.org/10.1016/s0002-9610(99)00096-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Fentiman, IanS. "BREAST CANCER SCREENING." Lancet 331, no. 8598 (1988): 1336. http://dx.doi.org/10.1016/s0140-6736(88)92149-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Autier, Philippe. "Breast cancer screening." European Journal of Cancer 47 (September 2011): S133—S146. http://dx.doi.org/10.1016/s0959-8049(11)70157-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Amadori, D. "Breast cancer screening." European Journal of Cancer 34 (September 1998): S91. http://dx.doi.org/10.1016/s0959-8049(98)80369-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Witcombe, J. B., Nicholas Wald, Christopher Frost, Howard Cuckle, and Peter Oppenheimer. "BREAST CANCER SCREENING." Lancet 329, no. 8537 (1987): 859. http://dx.doi.org/10.1016/s0140-6736(87)91632-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Moss, Sue, Jocelyn Chamberlain, Ruth Ellman, Anne Ludbrook, Anne Rodway, and A. F. Macdonald. "BREAST CANCER SCREENING." Lancet 329, no. 8542 (1987): 1153–54. http://dx.doi.org/10.1016/s0140-6736(87)91716-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Vanderburgh, David. "Breast cancer screening." Politics and the Life Sciences 37, no. 1 (2018): 135–40. http://dx.doi.org/10.1017/pls.2018.3.

Full text

Abstract:

Cass R. Sunstein’s 2016 bookThe Ethics of Influence: Government in the Age of Behavioral Scienceprovides an extremely informative introduction to the science and ethics of the exercise of “influence” over others. As a longtime physician employed in both the public and private sectors, I now recognize that most of my formal training has been in the hard sciences, with little, if any, training in the appropriate influence of the decision-making processes of my patients and/or other health care professionals in institutional settings. Breast cancer screening is an excellent example of the conflic

APA, Harvard, Vancouver, ISO, and other styles

49

Jordan, Veronica, Muneeza Khan, and Donna Prill. "Breast Cancer Screening." Primary Care: Clinics in Office Practice 46, no. 1 (2019): 97–115. http://dx.doi.org/10.1016/j.pop.2018.10.010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Thornton, Hazel. "Breast cancer screening." Lancet 351, no. 9096 (1998): 145. http://dx.doi.org/10.1016/s0140-6736(05)78108-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!